FDA MedWatch - Ayurvedic Dietary Supplements by Shree Baidyanath: Consumer Advice Notice - Products Contain High Levels of Lead and/or Mercury

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: FDA MedWatch - Ayurvedic Dietary Supplements by Shree Baidyanath: Consumer Advice Notice - Products Contain High Levels of Lead and/or Mercury
MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

 

Ayurvedic Dietary Supplements by Shree Baidyanath: Consumer Advice Notice - Products Contain High Levels of Lead and/or Mercury

AUDIENCE: Consumers

ISSUE: Consumers who have used any of the Baidyanath brand Ayurvedic dietary supplements listed in the Consumer Advice Notice should stop using them and consult their health care provider. Testing by the New York Department of Health and the U.S. Food and Drug Administration (FDA) has found that these products contain high levels of lead and/or mercury, which can cause serious health problems. Excessive exposure to mercury can cause kidney or gastrointestinal problems with short-term use, while exposure over a month or longer could lead to neurological problems and potentially be fatal. High levels can also affect the development of the nervous system of a pregnant woman’s unborn child. Some signs of mercury poisoning may include loss of coordination, vision or hearing, "pins and needles" sensations usually in the hands, feet, and around the mouth, or muscle weakness.

BACKGROUND: The products are manufactured by Shree Baidyanath Ayurved Bhawan in India and sold in the United States at retail and via the Internet. One major retailer has recalled the products. The FDA is working to identify other companies that may have sold the products.

RECOMMENDATION:

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch Safety Alert, including a link to the Consumer Advice Notice, at: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm463213.htm


This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux